In addition, studies have reported that the expression of MED19 was positively correlated with the expression of bone morphogenetic protein 2 (BMP2) in bladder urothelial carcinoma bone metastasis and invasion (20). Here, BMP2 is linked to bladder transitional cell carcinoma.